EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU)

CUSIP: G3141W114

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / UNIT 10/23/2027
Total 13F shares
1,609,868
Share change
-252,610
Total reported value
$16,059,000
Price per share
$10.00
Number of holders
15
Value change
-$2,500,032
Number of buys
2
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) as of Q2 2022

As of 30 Jun 2022, EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,609,868 shares. The largest 10 holders included Verition Fund Management LLC, Magnetar Financial LLC, Sio Capital Management, LLC, Wealthspring Capital LLC, Cowen Investment Management LLC, Sage Mountain Advisors LLC, HGC Investment Management Inc., Schechter Investment Advisors, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, and HRT FINANCIAL LP. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.